Business & Finance

FDA Grants First-Ever Breakthrough Designation for a Stroke-Rehabilitation Brain Implant

The FDA granted CorTec Breakthrough Device Designation for its Brain Interchange BCI — the first brain-computer interface targeting stroke motor rehabilitation, signaling a new era for therapeutic BCIs.

Naomi · 9 min read
Business & Finance

Astronomers Detect Unexpected Atmosphere on Tiny Icy World in the Outer Solar System

Quaoar, a dwarf planet in the Kuiper Belt, harbors a thin nitrogen atmosphere despite being too small to retain gas. The 2023 discovery challenges planetary science models.

Naomi · 7 min read
Business & Finance

AI Earbuds: The Wearable AI Revolution Hiding in Your Ears

AI earbuds are emerging as the next major computing platform. While smartwatches dominated headlines for years, a quieter device is gaining momentum: AI-powered earbuds that translate languages, summarize meetings, and process the world around you in real time.

Marcus Thorne · 4 min read
Business & Finance

The Physics of Dolphin Speed: What Supercomputer Simulations Revealed About Why Dolphins Are Built for Ocean Velocity

Dolphins hit 55 km/h using boundary layer physics that makes our best propellers look clumsy. Supercomputer simulations reveal how evolution cracked the code on underwater speed.

Elena Marsh · 5 min read
Business & Finance

Why Time Seems to Fly as You Get Older: The Neuroscience of Time Perception

Discover why years feel shorter as you age. Neuroscience reveals how your brain's internal clock, dopamine levels, and lack of novelty cause time to accelerate.

Mara Voss · 6 min read
Business & Finance

Iran Ceasefire and Ukraine: How the Middle East War Changed Kyiv's Fortunes

While the Iran war destabilised global energy markets and briefly boosted Russian oil revenues, it also handed Ukraine a strategic opportunity: Gulf nations hit by the same drones Russia uses against Kyiv are now buying Ukrainian defence expertise and technology.

Declan Brennan · 5 min read
Business & Finance

The Science of Suzetrigine: How the FDA's New Opioid-Free Painkiller Actually Ends Chronic Pain

Suzetrigine (JournaVX) is the first FDA-approved non-opioid analgesic targeting peripheral nerve sodium channels — offering pain relief without CNS effects or addiction risk.

Declan Webb · 5 min read
Business & Finance

The Seahawks Sale Saga: What the Zuckerberg-Cook Bidding Drama Reveals About $10 Billion NFL Franchises

Within 48 hours, two of the world's wealthiest men were said to be eyeing the Super Bowl champions. Then both denied it. Inside the secretive, high-stakes world of NFL franchise sales.

James Callahan · 6 min read
Business & Finance

EU AI Act August 2026: US Companies Face the Compliance Cliff

With the EU AI Act's August 2, 2026 deadline confirmed and trilogue negotiations stalled, US companies deploying AI in Europe face a compliance cliff with fines up to 30 million euros. Here is what you need to do now.

Nadia Petrov · 5 min read
Business & Finance

Big Tech's $700 Billion AI Bet: Inside the Hyperscaler Infrastructure Boom

Alphabet, Amazon, Meta, and Microsoft are on track to spend $700 billion on AI infrastructure in 2026. Here is where the money is going, who is winning, and why investors are already split on whether it is all worth it.

Marcus Webb · 4 min read
Business & Finance

AI Chatbots for Australian Small Businesses: What the 77% Need to Know

With surveys reporting anywhere from 25% to 84% of Australian small businesses using AI, it's hard to know where the truth sits. We cut through the noise to find out what the late-majority actually need to know before adopting chatbots.

Marcus Torres · 6 min read
Business & Finance

Apple's Record $111B Quarter and the CEO Who Inherits a Memory Cost Crisis

Apple posted $111.2 billion in revenue for Q2 2026, its first Q2 crossing the $100 billion threshold. The headline number masks a leadership transition and a mounting memory cost problem that will define John Ternus's first months as CEO.

Elena Kowalski · 4 min read